Monday, December 23, 2024
HomeTagsA.forall

A.forall

A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval

A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics